| TRADING CENTER |
| INTERVIEW-Illumina CEO sees rev growth resuming in 2010 - Reuters | |
| Illumina Announces $100 Million Share Repurchase Program - Business Wire | |
| Illumina to Present at the Piper Jaffray "Unplugged" Health Care Conference - Business Wire | |
| 5 Superball Stocks - MotleyFool.com | |
| 4-Star Stocks Poised to Pop: Sequenom - MotleyFool.com | |
| Critical Alerts For Visa, Schlumberger, Celgene, Illumina, and American Water Works R... - PR Newswire | |
| Trading Overview for Sequenom Inc. Issued by StockPreacher.com - GlobeNewswire | |
| Illumina Announces Scale-Up of Genome Analyzers at The Broad Institute - Business Wire |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| AMGN | Amgen Inc | 56.85 | 0.30 / 0.53% | 10.87 |
| GILD | Gilead Sciences Inc | 46.59 | 0.33 / 0.71% | 17.99 |
| CELG | Celgene Corporation | 55.97 | -0.56 / -0.99% | 67.43 |
| 2008 Revenue: | $573.2 M | Headquarters: San Diego, CA |
| Employees: | 1,536 | CEO: Jay T. Flatley |
| Net Income: | $50.5 M | Industry: Biotechnology |
| Market Cap: | $3.6 B | Website: www.illumina.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| ILMN | 28.32 | -0.66 / -2.28% | 28.98 | 29.18 | 27.63 | Profile Chart News |